Alvotech (ALVOW) Financials

ALVOW Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 1.6 billion 1.8 billion
March 31, 2026 1.4 billion 1.7 billion
Dec. 31, 2025 1.5 billion 1.8 billion
Sept. 30, 2025 1.4 billion 1.6 billion

ALVOW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -47.7 million ?
March 31, 2026 -106.6 million 2.3 million
Dec. 31, 2025 -71.5 million 16.1 million
Sept. 30, 2025 -74.5 million -3.4 million

ALVOW Net Income

No data available :(

ALVOW Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 142.8 million 1.3 billion 134.0 million
March 31, 2026 63.8 million 1.3 billion 147.7 million
Dec. 31, 2025 172.4 million 1.3 billion 150.1 million
Sept. 30, 2025 42.8 million 1.1 billion 157.8 million

ALVOW Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 356.8 million
March 31, 2026 330.3 million
Dec. 31, 2025 279.2 million
Sept. 30, 2025 300.2 million

ALVOW Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 27.9 million 21.9 million 43.6 million -
March 31, 2026 46.2 million 24.5 million 25.7 million -
Dec. 31, 2025 8.6 million 39.7 million 19.6 million -
Sept. 30, 2025 18.9 million 51.6 million 26.0 million -

ALVOW Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 105.8 million 52.2 million
March 31, 2026 105.9 million 46.1 million
Dec. 31, 2025 166.4 million 61.3 million
Sept. 30, 2025 114.0 million 35.0 million

ALVOW

Price: $0.30

52 week price:
0.30
1.52

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 3.0 billion

Links: